Innovation has always been part of our DNA 🧬 – but what drives us is people. 💙
At our new high-potency development and manufacturing site in Hyderabad, India, we are taking a meaningful step forward in oncology 🎗️ – with one goal in mind: helping cancer patients worldwide access better therapies faster and more affordably.
Operational since 2024, the state-of-the-art facility brings together science, technology and purpose. It enables the development and production of next generation oncology medicines – supporting the full journey from early research to commercial manufacturing, with a growing pipeline of about 25 cancer medicines. 💊
But beyond capabilities and scale, this site is about impact. 🌍 Global cancer cases are projected to increase by nearly 50% by 2040 – intensifying the need for more scalable, better therapies.
With advanced containment technologies up to OEB 5, we can safely handle highly potent compounds. By producing study medications for pilot bio studies in-house, we help shorten the path from development to real-world patient care.
And because responsibility matters at every level, the facility was designed as a green building, powered partly by a solar roof ☀️ – reflecting our commitment to sustainable progress. 🌱
At TiefenbacherGroup, every innovation is guided by our purpose of pioneering healthcare by making medicines more affordable, more available and better than before.
That is what we are working towards every day. 💙
